TLR7 and influenza: The present report demonstrates that surface charge and composition of liposomal formulations of the TLR7/8 agonist INI-4001 are crucial in shaping their biocompatibility as well as humoral and cell-mediated immunogenicity when combined with the influenza antigen H7.